Intestinal Behçet's disease with pyoderma gangrenosum successfully treated with the combination therapy of adalimumab and glucocorticoids

Mod Rheumatol. 2018 Sep;28(5):901-905. doi: 10.3109/14397595.2016.1174327. Epub 2016 May 4.

Abstract

A 24-year-old male presented with orogenital ulcers, folliculitis, and progressive painful skin ulcers with a raised inflammatory border. Colonoscopy revealed volcano-shaped intestinal ulcers in the ascending colon, and hence, he was diagnosed as intestinal Behçets disease (BD) with pyoderma gangrenosum (PG). Treatment with systemic glucocorticoids and adalimumab dramatically improved the patient's symptoms. Our case demonstrates that early induction of adalimumab may contribute to the successful treatment of such difficult-to-treat conditions as intestinal BD with PG.

Keywords: Adalimumab; Intestinal Behçets disease; Pyoderma gangrenosum.

Publication types

  • Case Reports

MeSH terms

  • Adalimumab / administration & dosage
  • Adalimumab / therapeutic use*
  • Behcet Syndrome / complications
  • Behcet Syndrome / drug therapy*
  • Combined Modality Therapy
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use*
  • Humans
  • Male
  • Pyoderma Gangrenosum / complications
  • Pyoderma Gangrenosum / drug therapy*
  • Young Adult

Substances

  • Glucocorticoids
  • Adalimumab